Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses.
Viral myocarditis is an important human disease, and reovirus-induced murine myocarditis provides an excellent model system for study. Cardiac myocytes, like neurons in the central nervous system, are not replenished, yet there is no cardiac protective equivalent to the blood-brain barrier. Thus, cardiac myocytes may have evolved a unique antiviral response relative to readily replenished cell types, such as cardiac fibroblasts. Our previous comparisons of these two cell types revealed a conundrum: reovirus T3D induces more beta-interferon (IFN-beta) mRNA in cardiac myocytes, yet there is a greater induction of IFN-stimulated genes (ISGs) in cardiac fibroblasts. Here, we investigated possible underlying molecular determinants. We found that greater basal expression of IFN-beta in cardiac myocytes results in greater basal activated nuclear STAT1 and STAT2 and greater basal ISG mRNA expression and provides greater basal antiviral protection relative to cardiac fibroblasts. Conversely, cardiac fibroblasts express greater basal IFN-alpha/beta receptor 1 (IFNAR1) and greater basal cytoplasmic Jak1, Tyk2, STAT2, and IRF9, leading to a greater increase in reovirus T3D- or IFN-induced nuclear activated STAT1 and STAT2 and greater induction of ISGs for a greater IFN-induced antiviral protection relative to cardiac myocytes. Our results suggest that high basal IFN-beta expression in cardiac myocytes prearms this vulnerable, nonreplenishable cell type, while high basal expression of IFNAR1 and latent Jak-STAT components in adjacent cardiac fibroblasts renders these cells more responsive to IFN and prevents them from inadvertently serving as a reservoir for viral replication and spread to cardiac myocytes. These studies provide the first indication of an integrated network of cell-type-specific innate immune components for organ protection.
Zurney
Jennifer
J
Department of Microbiology, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, North Carolina 27606, USA.
Howard
Kristina E
KE
Sherry
Barbara
B
D000818:Animals; D002478:Cells, Cultured; D005347:Fibroblasts / Q000276:immunology* / Q000821:virology; D005786:Gene Expression Regulation; D006801:Humans; D016898:Interferon-alpha / Q000235:genetics / Q000378:metabolism; D016899:Interferon-beta / Q000235:genetics / Q000378:metabolism; D053612:Janus Kinases / Q000235:genetics / Q000378:metabolism*; D007739:L Cells; D012089:Mammalian orthoreovirus 3 / Q000472:pathogenicity; D051379:Mice; D018345:Mice, Knockout; D009205:Myocarditis / Q000276:immunology* / Q000821:virology*; D032383:Myocytes, Cardiac / Q000276:immunology* / Q000821:virology; D030102:Orthoreovirus, Mammalian / Q000472:pathogenicity; D053633:Receptor, Interferon alpha-beta / Q000235:genetics / Q000378:metabolism*; D012088:Reoviridae Infections / Q000276:immunology / Q000821:virology; D050791:STAT Transcription Factors / Q000235:genetics / Q000378:metabolism*
C508032:Ifnar1 protein, mouse; D016898:Interferon-alpha; D050791:STAT Transcription Factors; D053633:Receptor, Interferon alpha-beta; D016899:Interferon-beta; D053612:Janus Kinases